H.R. 9347 aims to enhance protections against child labor violations in the United States. The bill likely includes measures to strengthen enforcement of existing child labor laws, increase penalties for violations, and improve monitoring of workplaces where children are employed. It may also introduce new regulations to prevent exploitation and ensure the safety and well-being of minors in the workforce.
Media outlets supportive of H.R. 9347 have praised the bill as a necessary step to protect vulnerable children from exploitation in the workforce. Advocates highlight the importance of ensuring that children can focus on education and personal development rather than being subjected to harmful labor practices. The bill is seen as a strong commitment to upholding children's rights and promoting a safer environment for youth.
Critics of H.R. 9347 express concerns that the bill may impose overly burdensome regulations on businesses, particularly small enterprises that rely on seasonal or part-time help. Some argue that the increased penalties could lead to unintended consequences, such as discouraging youth employment opportunities. Opponents also worry that the bill may not effectively address the root causes of child labor violations and could create additional bureaucratic hurdles.
The analysis of H.R. 9347, aimed at strengthening protections against child labor violations, reveals no direct industry overlaps between the bill's subject matter and the sponsor Rosa DeLauro's top donor industries. While there is lobbying activity in related policy areas, such as from Altria Client Services and the American College of Clinical Pharmacy, these entities do not have a direct connection to child labor issues. The total lobbying amounts from these organizations are significant, with Altria contributing $40,000 and the American College of Clinical Pharmacy contributing $144,981, but they do not indicate a conflict regarding the bill's focus on child labor protections. Therefore, the risk of conflict of interest is assessed as low, as the financial interests of the donors do not appear to influence the legislative intent of the bill.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| AMERICAN COLLEGE OF CLINICAL PHARMACY | AMERICAN COLLEGE OF CLINICAL PHARMACY | $144,981 |
| ALTRIA CLIENT SERVICES | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $40,000 |
| CROHN'S & COLITIS FOUNDATION | CROHN'S & COLITIS FOUNDATION | $40,000 |
| GOTRIANGLE | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $30,000 |
| AFRICAN AMERICAN ALLIANCE OF CDFI CEOS | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $20,000 |
| BRISTOL MYERS SQUIBB | ALEXANDER J. BECKLES, L.L.C. | $20,000 |
| CITY OF GLADEWATER, TEXAS | LONE STAR CONSULTING, LLC | $12,000 |
| CITY OF CRANDALL, TEXAS | LONE STAR CONSULTING, LLC | $10,000 |
| CITY OF JUSTIN, TEXAS | LONE STAR CONSULTING, LLC | $10,000 |
| THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | MAGILL ASSOCIATES, LLC | undisclosed |
| OPPORTUNITIES INDUSTRIALIZATION CENTER OF AMERICA, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| LUMBEE TRIBE HOLDINGS, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| CITY OF CLEVELAND, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
| CITY OF RIO HONDO, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
| HOWARD COUNTY, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Rosa DeLauro, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
